CSF2 and Miyoshi myopathy: In MM, vaccines are often considered to have the greatest potential in combination with auto-HSCT or other effective therapies with immunomodulatory mechanisms of action, such as MM GM-CSF-secreting vaccine in combination with lenalidomide, and the vaccines against PD-L1 (93, 94).